Ascendis CEO on first FDA application: "Proud of what we've achieved"
Ascendis Pharma founder and CEO Jan Møller Mikkelsen is proud that the firm's first drug Transcon hGH has been sent for approval. Next stop is making the drug leading in the world.
BY KEVIN GRØNNEMANN, TRANSLATED BY NIELSINE NIELSEN
Ascendis Pharma has come a long way since the experienced pharmaceutical executive Jan Møller Mikkelsen founded the company in 2007.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
.jpg&w=384&q=75){kind=logo}
